Insider Cluster (2 insiders) ·Filed Aug 3, 2026

ALKS

Alkermes plc.
NEUTRAL
Impact 3/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $536K total
Actionable Insight • Neutral

The insider sales are too small relative to market cap to be a standalone signal. Monitor for any additional insider selling in the next 30 days—a larger cluster would amplify the bearish read from the Q2 EPS miss. The Q2 earnings miss and widened GAAP loss guidance are the more material events for ALKS stock direction.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
ALKS ▼ -4.97% at T+20d
NEUTRAL call ✗ call lost -4.97% · α vs SPY -3.73% · entry $49.67 → $47.20
Next anchor: T+60d in 25d
Latest observation: T+39 -39.24% FF3 residual α
Entry anchored
Aug 3, 06:28 PM ET
via exchange tick
T+1d
-0.12%
call -0.12% · α +0.08%
$49.61
settled 8w ago
T+5d
-0.93%
call -0.93% · α -0.83%
$49.21
settled 8w ago
T+20d
-4.97%
call -4.97% · α -3.73%
$47.20
settled 5w ago
T+60d
—
call — · α —
—
in 25d

Price Chart

Loading chart...

Executive Summary

Two Alkermes insiders (EVP R&D/CMO and EVP/CLO) sold a combined $536K in open-market shares on August 3, 2026, one week after the company reported Q2 earnings that missed consensus EPS by a wide margin ($0.00 actual vs $0.29 expected). The sales follow option exercises by the CMO and appear to be liquidity-driven post-vesting, but the timing—immediately after a significant earnings miss and widened GAAP net loss guidance—raises caution. At $8.2B market cap, the $536K represents only ~0.007% of market cap, well below the 0.1% materiality threshold, making this a routine cluster in absolute dollar terms.

Key Financial Metrics

Direction
selling
Total Value
$536.0K
Insiders
2

Key Facts

  • Two insiders sold a combined $536K in open-market shares on August 3, 2026
  • EVP R&D/CMO Craig Hopkinson sold 9,000 shares at $48.58 after exercising options
  • EVP/CLO David Gaffin sold 2,034 shares at $48.58
  • Sales occurred 7 days after Q2 2026 earnings miss ($0.00 EPS vs $0.29 consensus)
  • Total sales represent ~0.007% of $8.2B market cap—trivial relative to company size
  • CMO's option exercises (4,896 shares at $24.59, 104 shares at $19.34) were non-cash events
  • No 10b5-1 plan disclosed, but post-vesting sales pattern is routine

Financial Impact

Total insider sales of $536K, or ~0.007% of market cap—immaterial

insider ownershipdilution

Risk Factors

  • Further insider selling could signal management's lack of confidence post-earnings miss
  • Q2 GAAP net loss guidance widened to ($95M)-($115M) due to CVR charge may pressure stock
  • CEO transition to Blair Jackson on August 1 adds leadership uncertainty

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ALKS-1785798811359
18 reports for ALKS
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +25.88%May 12, 2026
Filters
Rows
Reports for ALKS — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
8-K
NEUTRAL ★ 2/10
$46.07 $42.13▼ −8.55%▼ −11.12%$41.64 (−9.62%)
Sep 3, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $45.83▼ −0.59%▲ +0.62%$41.64 (−9.67%)
Aug 3, 2026
8w ago
Insider Cluster
BEARISH ★ 4/10
$49.67 $49.21▲ +0.93%▲ +0.83%$41.64 (+16.17%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$49.67 $49.21▼ −0.93%▼ −0.83%$41.64 (−16.17%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.67 $49.21▼ −0.93%▼ −0.83%$41.64 (−16.17%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 6/10
$50.50 $49.53▲ +1.92%▲ +4.19%$41.64 (+17.54%)
Jul 8, 2026
12w ago
8-K
NEUTRAL ★ 3/10
$54.29 $51.60▼ −4.95%▼ −5.82%$41.64 (−23.30%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$55.14 $51.94▼ −5.80%▼ −6.29%$41.64 (−24.48%)
Jun 4, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$42.80 $44.28▲ +3.46%▲ +2.89%$41.64 (−2.71%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$41.19 $44.29▲ +7.53%▲ +10.50%$41.64 (+1.10%)
Showing 10 of 18

US Market Status

Market Open — Closes in 2h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 3, 2026